Protracted neurobehavioral and microRNA deficits by acute nicotine dependence in mice
Abstract
Acute dependence to nicotine can rapidly elicit withdrawal symptoms. However, protracted withdrawal signs from acute nicotine dependence have not been explored. Here, we demonstrate that acute nicotine dependence induces delayed neurobehavioral defects in mice. Acute nicotine dependence led to impairment in passive avoidance but without changes in innate anxiety or learning/memory. Concurrently, F-actin level in the dorsal striatum was aberrantly increased, striatal dendritic spine density was reduced, and striatal neural population activity was diminished after acute nicotine dependence. The smoking-related and synapse-associated microRNA miR-27b was decreased in the dorsal striatum throughout the protracted phase of acute nicotine dependence. In silico analysis with empirical validation revealed the neuronal membrane-associated gene Marcks as a direct inhibition target of miR-27b, and that striatal Marcks was aberrantly enhanced after acute nicotine dependence. Our data collectively indicate that acute nicotine dependence accompanies a series of protracted neurobehavioral sequelae with striatal structural, electrophysiological, and molecular dysfunctions. Early nicotine withdrawal causes a long-lasting impairment in passive avoidance, accompanied by aberrant changes in microRNA, neural activity, and dendritic spines in the dorsal striatum.
Read the paper
Related studies
- Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics
- Challenges in Chagas Disease Drug Development
- T Cell Specificity: A Great Challenge in Chagas Disease
- Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in mice
- Rapid Molecular Detection of Terbinafine-resistant Dermatophytes
- Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an Open Source Drug discovery approach
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.